SCHEMBL12379905

SCHEMBL12379905

CC(C)c1cccc(C(C)C)c1/N=C\c1c2ccccc2cc2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AMY1A P0DUB6 1/20 0.43
GAA P10253 4/20 0.40
MAPT P10636 4/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
KMT2A Q03164 10/20 0.38
POLB P06746 3/20 0.38
LMNA P02545 2/20 0.38
MEN1 O00255 6/20 0.37
RAD52 P43351 1/20 0.37
HCRTR1 O43613 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
SIGMAR1 Q99720 2/20 0.35
ERBB2 P04626 1/20 0.35
CYP1A2 P05177 1/20 0.35
FYN P06241 1/20 0.35
MAOA P21397 1/20 0.35
ACHE P22303 1/20 0.35
AHR P35869 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18489585 0.80 KDM4E (0.58) GAAMAPTKMT2APOLBLMNA
SCHEMBL18489587 0.80 KDM4E (0.58) GAAMAPTKMT2APOLBLMNA
SCHEMBL18489492 0.79 ALDH1A1 (0.47) MAPTHTTKMT2APOLBLMNA
SCHEMBL18489491 0.79 ALDH1A1 (0.47) MAPTHTTKMT2APOLBLMNA
SCHEMBL18525565 0.77 KMT2A (0.42) GAAMAPTKMT2APOLBLMNA
SCHEMBL18489473 0.77 DHODH (0.48) GAAMAPTHTTKMT2ALMNA
SCHEMBL18489474 0.77 DHODH (0.48) GAAMAPTHTTKMT2ALMNA
SCHEMBL18489487 0.76 ALDH1A1 (0.50) GAAMAPTHTTKMT2ALMNA
SCHEMBL18489488 0.76 ALDH1A1 (0.50) GAAMAPTHTTKMT2ALMNA
SCHEMBL30933094 0.75 KMT2A (0.60) GAAMAPTHTTKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998895-B2 Catalysts for olefin polymerization E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-08-16 US disclosed
US-7998895-B2 Catalysts for olefin polymerization E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-08-16 US disclosed
US-20100222531-A1 CATALYSTS FOR OLEFIN POLYMERIZATION E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-09-02 US disclosed
US-20100029469-A1 CATALYSTS FOR OLEFIN POLYMERIZATION E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-02-04 US disclosed
US-20100029469-A1 CATALYSTS FOR OLEFIN POLYMERIZATION E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-02-04 US disclosed
US-7439314-B2 Catalysts for olefin polymerization E. I. DU PONT DE NEMOURS AND COMPANY (US) 2008-10-21 US disclosed
US-7439314-B2 Catalysts for olefin polymerization E. I. DU PONT DE NEMOURS AND COMPANY (US) 2008-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222531-A1 CATALYSTS FOR OLEFIN POLYMERIZATION PORCN, PUF60, CAD AMY1A 2174/4885GAA 3973/4885MAPT 1503/4885
US-20100029469-A1 CATALYSTS FOR OLEFIN POLYMERIZATION PORCN, PUF60, CAD AMY1A 2174/4885GAA 3973/4885MAPT 1503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.